The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Tristel's Hospital Surface Disinfection Focus Helps It Weather Virus

Mon, 19th Oct 2020 11:16

(Alliance News) - Infection prevention products provider Tristel PLC on Monday said annual profit grew as hospital surface disinfectant sales helped to offset a decline in medical device decontamination sales.

Revenue for the financial year ended June 30 was GBP31.7 million, up 21% from GBP26.2 million the year before. Pretax profit rose 40% to GBP6.6 million from GBP4.7 million.

"We delivered another very sound performance in a year turned on its head by Covid-19, the impact of which was a reduction of GBP0.5 million in medical device decontamination sales and an increase of GBP2 million in hospital surface disinfectant sales," said Chief Executive Paul Swinney.

During the March to June period, when the impact of Covid-19 was at its greatest, global sales were GBP11.8 million compared to GBP9.1 million in the same period last year, an increase of 30%. Medical device decontamination product sales accounted for 74% of sales in this period, while sales of hospital surface disinfection products accounted for 15%.

Tristel said it was able to steer its way through the early Covid-19 crisis by mitigating the fall in demand for its primary product portfolio via a rapid increase in supply of its hospital surface disinfection products.

Turning to the recently-started financial year, Swinney said the company has seen a "gradual recovery" in demand for medical device products in all its markets in the first quarter.

"Since February, we have acquired a significant number of hospital customers for our surface disinfectant products. We expect this build-up of our hospital surface disinfection business to continue throughout this and future years. It is a key strategic focus of the company," he added.

While further Covid-19 lockdowns may "temporarily interrupt our group's forward momentum", Tristel is optimistic for the year's trading outlook.

Tristel raised its full-year dividend by 12% to 6.18 pence.

Shares in Tristel were up 2.2% at 509.00p in London on Monday.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

Related Shares

More News
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

18 Apr 2024 12:42

IN BRIEF: Tristel CEO Paul Swinney sells GBP230,000 in shares

Tristel PLC - Newmarket, England-based maker of infection prevention products - Chief Executive Officer Paul Swinney sells 50,000 shares at 462 pence,...

5 Apr 2024 13:52

UK dividends calendar - next 7 days

14 Mar 2024 15:06

UK dividends calendar - next 7 days

26 Feb 2024 12:18

New Tristel products recommended for UK, EU certification

(Sharecast News) - Infection prevention products developer Tristel announced the successful conclusion of all reviews required under the UK and Europe...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.